What is Ginkgo Bioworks's operating lease liabilities?

Ginkgo Bioworks (DNA) reported operating lease liabilities of -$5M in Q1 2026.

How has Ginkgo Bioworks's operating lease liabilities changed year-over-year?

Ginkgo Bioworks's operating lease liabilities decreased by 4.3% year-over-year, from -$4.79M to -$5M.

What is the long-term trend for Ginkgo Bioworks's operating lease liabilities?

Over 2 years (2023 to 2025), Ginkgo Bioworks's operating lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$22.8M to -$27.93M.

Ginkgo Bioworks DNA Operating lease liabilities

Operating lease liabilities at other companies

ClearPoint NeuroCLPT

——

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's operating lease liabilities?: Ginkgo Bioworks (DNA) reported operating lease liabilities of -$5M in Q1 2026.
How has Ginkgo Bioworks's operating lease liabilities changed year-over-year?: Ginkgo Bioworks's operating lease liabilities decreased by 4.3% year-over-year, from -$4.79M to -$5M.
What is the long-term trend for Ginkgo Bioworks's operating lease liabilities?: Over 2 years (2023 to 2025), Ginkgo Bioworks's operating lease liabilities has grown at a 10.7% compound annual growth rate (CAGR), from -$22.8M to -$27.93M.